Vera Therapeutics, Inc. (VERA) › Shareholders' EquityVera Therapeutics, Inc. (VERA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$36.55M2020: -$89.35M2021: $69.59M2022: $76.91M2023: $101.69M2024: $577.15M2025: $604.52M$604.52M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$604.52M+4.7%2024$577.15M+467.6%2023$101.69M+32.2%2022$76.91M+10.5%2021$69.59M+177.9%2020-$89.35M-144.5%2019-$36.55M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share